Half a million people using weight-loss jabs are at risk of invalidating their travel insurance this summer, experts warn.

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

India's top endocrinologist, Dr Ambrish Mithal has come out with a very well timed and a much needed explainer on the new crop of weight loss drugs that have flooded the market. Entitled, "The Weight ...

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

Fitness experts expect clients to leave their programmes as weight loss jabs become available on the NHS. Rami Mwamba spoke ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...